Beijing Science Sun Pharmaceutical Co (SZSE:300485) Days Sales Outstanding : 39.76 (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Beijing Science Sun Pharmaceutical Co Days Sales Outstanding?

Beijing Science Sun Pharmaceutical Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥47.7 Mil. Beijing Science Sun Pharmaceutical Co's Revenue for the three months ended in Mar. 2024 was ¥109.5 Mil. Hence, Beijing Science Sun Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 39.76.

The historical rank and industry rank for Beijing Science Sun Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

SZSE:300485' s Days Sales Outstanding Range Over the Past 10 Years
Min: 3.5 Med: 38.66 Max: 61.02
Current: 46.34

During the past 13 years, Beijing Science Sun Pharmaceutical Co's highest Days Sales Outstanding was 61.02. The lowest was 3.50. And the median was 38.66.

SZSE:300485's Days Sales Outstanding is ranked better than
74.67% of 995 companies
in the Drug Manufacturers industry
Industry Median: 71.56 vs SZSE:300485: 46.34

Beijing Science Sun Pharmaceutical Co's Days Sales Outstanding declined from Mar. 2023 (49.93) to Mar. 2024 (39.76).

Beijing Science Sun Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Beijing Science Sun Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Science Sun Pharmaceutical Co Days Sales Outstanding Chart

Beijing Science Sun Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

61.02

44.88

35.85

41.53

47.08

Beijing Science Sun Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															49.93	42.73	46.13	60.01	39.76

Competitive Comparison of Beijing Science Sun Pharmaceutical Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Science Sun Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beijing Science Sun Pharmaceutical Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beijing Science Sun Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Beijing Science Sun Pharmaceutical Co's Days Sales Outstanding falls into.

Beijing Science Sun Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Beijing Science Sun Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (75.98	+	46.951)	/	2 )	/	476.57	*	365
=	61.4655					/	476.57	*	365
=	47.08

Beijing Science Sun Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (46.951	+	48.515)	/	2 )	/	109.535	*	365 / 4
=	47.733					/	109.535	*	365 / 4
=	39.76

Beijing Science Sun Pharmaceutical Co (SZSE:300485) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Beijing Science Sun Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Beijing Science Sun Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Science Sun Pharmaceutical Co (SZSE:300485) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Science Sun Pharmaceutical Co Ltd (SZSE:300485) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

No. 8, Xingsheng Street, Yizhuang Economic and Technological Development Zone, Beijing, CHN, 100176

Website

http://www.ssyy.com.cn

Beijing Science Sun Pharmaceutical Co Ltd is engaged in the research and development, production and sales of biological drugs. The company products can be divided into cardiovascular series, immune regulation series, nervous system series, and other natural or biotech pharmaceuticals. Its products include Injection Tiopronin, Cybex, Xel, Lichinga, Plasmin Injection and Race liter.

Executives

Ma Li	Directors, executives
Kong Shuang Quan	Executives
Li Jian Hua	Director
Ma Biao	Directors, executives
Li Zhi Bing	Supervisors
Zhang Fan	Executives

Beijing Science Sun Pharmaceutical Co (SZSE:300485) Headlines

No Headlines